ORLACCHIO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 9.879
EU - Europa 1.829
AS - Asia 319
SA - Sud America 6
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 12.042
Nazione #
US - Stati Uniti d'America 9.874
UA - Ucraina 414
PL - Polonia 348
DE - Germania 258
IE - Irlanda 225
CN - Cina 203
FR - Francia 179
IT - Italia 98
FI - Finlandia 86
KR - Corea 84
GB - Regno Unito 72
SE - Svezia 53
RU - Federazione Russa 33
NL - Olanda 29
BE - Belgio 21
JP - Giappone 14
CA - Canada 4
EG - Egitto 4
IN - India 4
CL - Cile 3
ES - Italia 3
KG - Kirghizistan 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
EU - Europa 2
PT - Portogallo 2
RO - Romania 2
UZ - Uzbekistan 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
DM - Dominica 1
FK - Isole Falkland (Malvinas) 1
IQ - Iraq 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
SG - Singapore 1
TN - Tunisia 1
Totale 12.042
Città #
Woodbridge 2.627
Houston 1.846
Wilmington 1.454
Fairfield 797
Ann Arbor 659
Jacksonville 407
Kraków 348
Ashburn 334
Cambridge 292
Seattle 285
Dublin 225
Chandler 203
Medford 176
Beijing 114
Lawrence 84
Dearborn 66
Menlo Park 50
San Diego 41
Mülheim 33
New York 33
Milan 23
University Park 21
Zhengzhou 21
London 20
Mountain View 20
Norwalk 20
Verona 19
Falls Church 17
Waanrode 16
Hefei 13
Redwood City 13
Rome 13
Nanjing 11
Chicago 10
Detroit 9
Saint Petersburg 6
Brussels 5
Indiana 5
Kunming 5
Mcallen 5
Fremont 4
Guangzhou 4
Hebei 4
Jinan 4
Palo Alto 4
Shanghai 4
Tokyo 4
Bologna 3
Helsinki 3
Islington 3
Prescot 3
Toronto 3
Xian 3
Ypsilanti 3
Cairo 2
Casarsa della Delizia 2
Chiswick 2
Defiance 2
Groningen 2
Kilburn 2
Leawood 2
Newry 2
Odessa 2
Prato 2
San Francisco 2
Shenyang 2
Tiranë 2
Turin 2
Bangalore 1
Baotou 1
Basra 1
Brisbane 1
Cagliari 1
Ceres 1
Chengdu 1
Columbus 1
Cupertino 1
Dong Ket 1
Dubai 1
Federal 1
Genova 1
Hangzhou 1
Hanoi 1
Hounslow 1
Jinhua 1
Kannur 1
Kumar 1
Lausanne 1
Madrid 1
Miami 1
Nürnberg 1
Perm 1
Perugia 1
Phnom Penh 1
Phoenix 1
Pizzo 1
Ranchi 1
Redmond 1
Roseau 1
Saint Paul 1
Totale 10.455
Nome #
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine 460
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 434
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 427
Silver syndrome variant of hereditary spastic paraplegia: A locus to 4p and allelism with SPG4 392
Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy 385
Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms 369
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients 368
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 348
SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis 338
Association study of the 5-hydroxytryptamine(6) receptor gene in Alzheimer's disease 338
New locus for hereditary spastic paraplegia maps to chromosome 1p31.1-1p21.1 331
Acanthocytosis as a predisposing factor non-ketotic hyperglycemia induced chorea-ballism 324
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 319
A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts 319
Clinical and genetic study of a large SPG4 Italian family 281
Hereditary spastic paraplegia:A novel mutation and expansion of the phenotype variability in SPG10 267
Late-onset spastic paraplegia: Aberrant SPG11 transcripts generated by a novel splice site donor mutation 150
Exome sequencing identifies a novel intronic mutation in ENG that causes recurrence of pulmonary arteriovenous malformations 145
Bridging Over the Troubled Heterogeneity of SPG-Related Pathologies: Mechanisms Unite What Genetics Divide 143
Neonatal SCA2 Presenting With Choreic Movements and Dystonia With Dystonic Jerks, Retinitis, Seizures, and Hypotonia 142
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 136
The role of reticulons in neurodegenerative diseases 135
Up-regulation of glycohydrolases in Alzheimer's Disease fibroblasts correlates with Ras activation 127
Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases 125
Increasing and persistent DWI changes in a patient with hereditary diffuse leukoencephalopathy with spheroids 123
1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study 123
A novel mutation in the SPG3A gene (atlastin) in hereditary spastic paraplegia 116
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis 116
Absence of linkage between familial amyotrophic lateral sclerosis and copper chaperone for the superoxide dismutase gene locus in two Italian pedigrees 113
Late-onset hereditary spastic paraplegia with thin corpus callosum caused by a new SPG3A mutation 110
Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: a novel mutation in the SPG11 gene and further evidence for genetic heterogeneity 109
Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneity 106
RNA interference as a tool for Alzheimer's disease therapy 104
Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE 104
PS1 Alzheimer's disease family with spastic paraplegia: the search for a gene modifier 103
Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS. 102
Application of long-range polymerase chain reaction in the diagnosis of X-linked dystonia-parkinsonism 102
MicroRNA Implications across Neurodevelopment and Neuropathology 99
Platelets release their lysosomal content in vivo in humans upon activation 99
Characterization of human Enah gene. 98
miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease 98
Spastic paraplegia in Romania: high prevalence of SPG4 mutations 97
Effects of Vitamin C on Fibroblasts from Sporadic Alzheimer’s Disease Patients 97
Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitus 97
Late-onset CMT2 associated with a novel missense mutation in the cytoplasmic domain of the MPZ gene 96
Research actuality in the genetics of stroke 95
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients 95
Nitric oxide depletion alters hematopoietic stem cell commitment toward immunogenic dendritic cells 95
Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease 95
Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12 94
Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease 93
Lack of SOD1 gene mutations and activity alterations in two Italian families with amyotrophic lateral sclerosis 93
Hereditary spastic paraplegia: Clinical-genetic characteristics and evolving molecular mechanisms 93
Novel SPG6 mutation p.A100T in a Japanese family with autosomal dominant form of hereditary spastic paraplegia 92
Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1 92
Identification of maternal uniparental isodisomy of chromosome 10 in a patient with mitochondrial DNA depletion syndrome 92
Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis 92
Platelet glycohydrolase activities: characterization and release 91
Caspase 3 activation and PARP cleavage in lymphocytes from newborn babies of diabetic mothers with unbalanced glycaemic control 91
Oromandibular dystonia associated with SCA36 90
Therapy with drug product AZD-103 may ease Alzheimer’s disease 90
Novel presenilin 1 mutations associated with early onset of dementia in a family with both early-onset and late-onset Alzheimer disease 90
Cathepsin D expression is decreased in Alzheimer's disease fibroblasts 88
Development of a New Tool for 3D Modeling for Regenerative Medicine 87
The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosus 86
Lack of association between Alzheimer's disease and the promoter region polymorphisms of the nicastrin gene 86
Clinical and genetic study of a large Italian family linked to SPG12 locus 83
Stem cells and neurological diseases 74
beta-hexosaminidase, alpha-D-mannosidase, and beta-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I 73
Hexosaminidase in Trichinella spiralis is a single protein with alpha- and beta-subunits catalytic activities 73
Alpha-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis 70
An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease 68
Purification and properties of human urinary beta-D-mannosidase 68
Constitutive expression of beta-N-acetylhexosaminidase in a microglial cell line: transcriptional modulation by lipopolysaccharide and serum factors 66
Beta-N-acetylhexosaminidase in peripheral blood lymphocytes and monocytes in the different forms and stages of multiple sclerosis 64
Activity levels of a beta1,6 N-acetylglucosaminyltransferase in lymphomonocytes from multiple sclerosis patients 64
Hereditary spastic paraplegia: clinical genetic study of 15 families 62
On the identification of two beta-D-mannosidase forms in human kidney and urine 60
Promoter characterization and structure of the gene encoding mouse lysosomal alpha-d-mannosidase 59
Alpha-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis 59
Non-replication of association between MAPT-SNCA synergistical interaction and susceptibility to Parkinson’s Disease in a southern European population 56
Elevated beta-N-acetylhexosaminidase activity in focal dystonia fibroblasts 55
Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease 55
Polymorphisms in the MAPT gene and risk of Parkinson disease in a Greek population: A case-control study. 49
Totale 12.093
Categoria #
all - tutte 32.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019828 0 0 0 0 0 0 0 0 0 0 456 372
2019/20203.068 262 236 227 366 244 357 240 335 277 236 104 184
2020/20211.401 106 191 112 166 92 92 159 116 110 57 175 25
2021/2022744 18 120 21 23 40 60 43 30 46 48 47 248
2022/2023693 104 56 9 53 55 206 66 21 52 0 52 19
2023/2024113 20 8 9 5 20 36 5 3 5 1 1 0
Totale 12.093